Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT06259019

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
PlaqueTec Ltd (from the registry)
Registry
  • NCT NCT06259019
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06259019. Allocation not applicable; no masking; primary purpose other. Start 2023-09-14 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
Acronym
BIOPATTERN
Intervention (Device)
Liquid Biopsy System (LBS)
Lead sponsor
PlaqueTec Ltd (class: industry)
Collaborator
Royal Papworth Hospital (class: other government)

Record details

Record id
cardio:ct-nct06259019
Content hash
cb84e35c81d8c2905f922c92d0649017998f374a442de8280c40e50e9b136089